Search filters

Filters
Clear All

Phase

  • 67
  • 68
  • 1
  • 81
  • 60
  • 13
  • 190
  • 556
  • 217
  • 9
  • 22
  • 528
  • 556
  • 3

Found 559 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

21 years - 79 years
All genders
Phase 1
The research study is being conducted to learn about the work of breathing support that an external breathing support device can provide compared to a person’s baseline ability. The research study is sponsored by RightAir Inc, the makers of the device being investigated, the AIR-AD cuirass ventilator. This study is …
18 years - 100 years
All genders
Phase 2
ABBV-CLS-7262 is a prodrug that is converted in vivo to the pharmacologically active parent compound A-1684909. A-1684909 is a central nervous system (CNS)-penetrant, eukaryotic translation initiation factor 2B (eIF2B) activator that attenuates the integrated stress response (ISR), a highly conserved cellular mechanism hypothesized to be important in the pathophysiology of …
 RREACH-PsO: Recruiting Racial/Ethnic minority Adults in Clinical researcH -   Psoriasis
18 years - 100 years
All genders
The purpose of this study is to understand the perceptions of clinical research studies among patients with psoriasis and to identify what motivates or prevents patients with psoriasis from participating in research. This study is particularly focused on understanding the perspectives of racial/ethnic minority adults living with psoriasis. The information …
 V7.3 Smoke Testing study
23 years - 90 years
All genders
This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). We will demonstrate that IPS cTBS results in significant target engagement in the form of reduction …
Learn More
Online study
 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
Phase 3
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study …
 Research Study on Whether a Combination of 2 Medicines  Works in People With Non-alcoholic Steatohepatitis (NASH)
18 years - 99 years
All genders
This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non alcoholic steatohepatitis (NASH). NNC0194-0499 is a new medicine which works in the liver. Semaglutide is a well-known medicine, which is already used by doctors to …
100 years or below
Accepts healthy volunteer
Female
Phase 1
Test Trial - v7.0What is the purpose of this study?This study is a randomized, open label, multicenter Phase II trial to evaluate the efficacy and safety of botensilimab (a novel Fc enhanced Tree depleting anti-CTLA4) and balstilimab (a novel anti-PD1) relative to ipilimumab and nivolumab in treatment naïve patients with …
 Food Rx: Food Supplementation Interventions to Improve Weight Loss for Adults With Food Insecurity and Obesity
18 years - 100 years
All genders
Phase 2
The purpose of this intervention research project is to conduct a randomized controlled trial in adults with obesity and food insecurity to assess whether behavioral weight loss treatment and providing food or resources for food can improve weight loss, diet quality, and perceived physical and mental health in individuals with obesity and food insecurity. …
 RevitaT2Di Pivotal Study (REVITALIZE 1)
21 years - 70 years
All genders
The Revitalize-1 Study will look at a potential procedure called duodenal mucosal resurfacing (DMR). The DMR procedure acts on the first layer (mucosa) of the duodenum (the part of the small intestine located immediately after the stomach). By removing an excess layer, the treatment may improve blood sugar control. This …
18 years - 69 years
All genders
Phase 2
Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused …
21 - 30 of 559